Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate read-only, idempotent, non-destructive behavior. The description adds rich behavioral details: data sources, handling of off-calendar fiscal years, sorting by primary metric, and citation URIs. No contradiction.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is relatively long but front-loaded with example invocations and key instructions. Every sentence adds meaningful information, though it could be slightly more concise without losing value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, no output schema), the description comprehensively explains input requirements, data sources, sorting, and output format (paired data + citation URIs). It leaves no essential gaps.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, baseline 3. Description adds value by interpreting the 'type' parameter as selecting data source and specifying that 'values' accepts tickers/CIKs for companies and drug names, with min/max constraints clearly stated.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly specifies the tool's function: side-by-side comparison of 2-5 companies or drugs, with distinct data sources (SEC EDGAR for companies, FAERS for drugs). It distinguishes itself from sibling tools like entity_profile and sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states to prefer this tool over sequential lookups for comparisons, provides example queries, and explains sorting behavior. It lacks explicit when-not-to-use guidance but is clear on context.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

Several tools are near-duplicates: ask_pipeworx_beta is described as currently identical to ask_pipeworx, and ask_pipeworx_grounded is the same router with extra verification. Malware sample searches also overlap across search_family, search_tag, search_signature, and recent_samples, while ai_visibility_check is wrapped by scan_competitor_ai_presence.

Naming Consistency3/5

The set mostly uses snake_case and verb-first names like get_sample_info and validate_claim, which is helpful. However, conventions are mixed across ask_pipeworx*, polymarket_*, pipeworx_*, search_*, and noun-style names like recent_samples and entity_profile, so there is no single predictable pattern.

Tool Count2/5

36 tools is already over the comfortable range, but the bigger issue is that the server is named Malwarebazaar while only about five tools actually deal with malware. The remaining tools belong to an unrelated data-research, prediction-market, memory, and subscription platform, making the count inappropriate for the server's apparent purpose.

Completeness2/5

For the MalwareBazaar domain, the set covers metadata lookups and filtered sample searches but lacks sample submission, retrieval, or deeper analysis workflow. The rest of the tool surface targets unrelated domains, so there is no coherent, complete lifecycle for either malware intelligence or the broader feature set.